Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
With
Adelphi Values
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, at least 18 years of age.
Subject is willing and able to provide written informed consent.
Subject must have a diagnosis of symptomatic Pulmonary Arterial Hypertension Type I as per the World Health Organization (WHO) clinical classification system.
Subject must have the cognitive and linguistic capabilities sufficient to allow them to actively participate in an interview lasting 30 minutes.
You may not be if
Subject has a diagnosis of other cardiac or pulmonary disease.
Subject has a Type II-V diagnosis of PAH, as per the WHO clinical classification system.
Subject is currently receiving treatment for PAH via modes of administration other than intravenously or orally.
Clareo Health | Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects
